AzTrials
AzTrials

Partial EdentulismDIGICLASPNCT07903662

Digital and Conventional Clasp-retained Partial Dentures (DIGICLASP)

An observational study of Partial Edentulism, run by University of Bern at 1 site in Switzerland.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This single-center prospective observational cohort study evaluates two fabrication workflows already in routine clinical use for clasp-retained removable partial dentures (RPDs): a digital workflow (Group 1) and a conventional workflow (Group 2). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Partial Edentulism
How many people
70 participants
Where
1 siteSwitzerland
Study dates
Nov 2026to Mar 2030
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Consecutive patients with an indication for a clasp-retained removable partial denture treated at the Department of Reconstructive Dentistry and Gerodontology, University of Bern (clinical, postgraduate and undergraduate student-course settings), during the data-collection period who consent to the two additional intraoral scans.

Who may be able to join

  • Adults aged 18 years or older
  • Indication for a clasp-retained removable partial denture, treated at the department during the data-collection period
  • Consent to the two additional, non-invasive intraoral scans performed during the framework try-in

Who cannot join

  • No consent to the study-specific additional measures
  • Minors
  • Persons unable to give informed consent

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Sebastian Hinz, Dr. med. dent. contact

+41 31 684 07 41

sebastian.hinz@unibe.ch

Nicole Schenk, Dr. med. dent. contact

+41 31 684 07 39

nicole.schenk@unibe.ch

Switzerland1 site
  • University of Bern, Department of Reconstructive Dentistry and Gerodontology

    Bern, Canton of Bern, 3010

    Sebastian Hinz, Dr. med. dent., +41 31 68407 41, sebastian.hinz@unibe.ch

    Nicole Schenk, Dr. med. dent., +41 31 684 0739, nicole.schenk@unibe.ch

Other trials in Switzerland

About this study

Official title: Digital and Conventional Fabrication of Clasp-retained Removable Partial Dentures: A Prospective Observational Evaluation of Clinical and Dental Laboratory Processes

This single-center prospective observational cohort study evaluates two fabrication workflows already in routine clinical use for clasp-retained removable partial dentures (RPDs): a digital workflow (Group 1) and a conventional workflow (Group 2). The fabrication workflow is selected as part of routine clinical care and is not assigned by the study. Separately for the digital and conventional workflows, the study describes the cumulative active clinical chairside time (primary), together with the number of clinical appointments, dental laboratory process times, quantitative and clinical framework fit, adjustment effort, final fit, and the frequency of rework and remake. Consecutive patients treated at the Department of Reconstructive Dentistry and Gerodontology, University of Bern, are included over a 36-month period. The analysis is purely descriptive; no causal inference, confirmatory hypothesis testing, or superiority assessment is planned.

Read the detailed description

Clasp-retained removable partial dentures are a frequent routine treatment at the Department of Reconstructive Dentistry and Gerodontology, University of Bern, including the undergraduate student course; approximately 100 are produced per year. Both a conventional workflow and a digital workflow are used in routine care. For internal process control, systematic prospective data on process efficiency, framework fit, adjustment effort, and rework or remake are currently lacking for these routinely used workflows.

This is a single-center, prospective, observational cohort study embedded in routine care. The fabrication workflow (digital = Group 1; conventional = Group 2) is chosen clinically as part of regular treatment and is not assigned, randomized, or otherwise influenced by the study; the workflow actually used is documented prospectively. An approximately balanced representation of both workflows and Kennedy classes is sought over the data-collection period, but no fixed allocation rule or quota is applied. No causal or superiority comparison between workflows is intended.

The only study-specific procedure is two additional, non-invasive intraoral scans performed during the already-scheduled framework try-in: one scan without the framework and one with the fully seated framework. For the second scan, an intraorally approved scan spray is applied to visible metal surfaces and removed afterwards. The two scans together take about 10 minutes and require no additional appointment. In addition, the finished framework is scanned extraorally in the laboratory as a reference, which adds no patient time. All other examinations and treatment steps are part of routine care.

Outcomes are described separately per workflow and setting using descriptive statistics. No sample-size calculation and no confirmatory hypothesis testing are performed.

Keywords
Jaw, Edentulous, Partially
Medical subject headings
Mouth, Edentulous

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07903662
Study groupRoleWhat they receive
Digital workflowPatients whose clasp-retained RPD is fabricated using the digital workflow (intraoral scan-based CAD and digital framework fabrication) as selected in routine clinical care. Group membership reflects the clinically chosen fabrication workflow and is not assigned by the study.
Conventional workflowPatients whose clasp-retained RPD is fabricated using the conventional workflow as selected in routine clinical care. Group membership reflects the clinically chosen fabrication workflow and is not assigned by the study.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cumulative active prosthesis-related clinical chairside time

    Cumulative active prosthesis-related clinical chairside time per participant, in minutes, summed across all treatment sessions from the first prosthesis-related appointment to definitive insertion. Includes regular clinical scanning required for fabrication, framework try-in and clinical adjustment, if required. Excludes waiting and interruption time, study-specific scanning procedures and framework planning/drawing. Reported separately for the digital and conventional fabrication workflows.

    Measured: From the first prosthesis-related appointment through definitive insertion, an average of 6 weeks per participant.

Secondary outcomes (11)
  1. Number of clinical appointments

    Number of clinical appointments per participant from the first prosthesis-related appointment to definitive insertion. Reported separately per workflow.

    Measured: Through completion of prosthetic treatment, an average of 6 weeks.

  2. Active dental laboratory technician time

    Active dental laboratory technician working time per participant, in minutes, recorded for predefined fabrication steps; idle time between steps is excluded. Reported separately per workflow.

    Measured: From receipt of the laboratory order to completion of framework fabrication, approximately 3-4 weeks after treatment initiation.

  3. Quantitative framework fit

    Three-dimensional surface distance between supporting tooth/ridge surfaces and the framework fitting surface, in micrometers, in predefined measurement regions, based on superimposition of an intraoral scan without the framework, an intraoral scan with the seated framework and an extraoral scan of the finished framework. Continuous measure; no clinical cut-off. Reported separately per workflow.

    Measured: At initial framework try-in, approximately 3-4 weeks after treatment initiation, before clinical adjustment.

  4. Number of participants whose framework meets all clinical fit and stability criteria before adjustment

    Four predefined yes/no criteria: seating of rests; adaptation of clasps and tooth-contacting components; adaptation of the major connector; stability under bilateral finger pressure. Reported separately per workflow.

    Measured: At framework try-in, approximately 3-4 weeks after treatment initiation, before clinical adjustment.

  5. Number of participants whose framework requires clinical adjustment

    Whether clinical adjustment of the framework is required (yes/no). Reported separately per workflow.

    Measured: At framework try-in, approximately 3-4 weeks after treatment initiation.

  6. Active clinical adjustment time

    Active clinical adjustment time per participant, in minutes, including participants without adjustment (0 minutes). Reported separately per workflow.

    Measured: At framework try-in, approximately 3-4 weeks after treatment initiation.

  7. Number of participants with clinically acceptable final framework fit

    Number of participants whose framework demonstrates clinically acceptable final fit (yes/no), assessed after completion of framework try-in and clinical adjustment, if required. Reported separately per workflow.

    Measured: At completion of framework try-in, approximately 3-4 weeks after treatment initiation.

  8. Number of participants whose framework requires laboratory rework

    Rework documented with predefined cause categories. Reported separately per workflow.

    Measured: Through completion of prosthetic treatment, an average of 6 weeks.

  9. Number of participants whose framework requires complete remake

    Remake documented with predefined cause categories. Reported separately per workflow.

    Measured: Through completion of prosthetic treatment, an average of 6 weeks.

  10. Total invoiced treatment cost

    Total invoiced treatment cost per participant, in Swiss francs (CHF): invoiced prosthesis-related clinical services plus dental laboratory costs from treatment initiation to definitive insertion; unrelated dental services excluded. Restricted to participants treated in the specialist (non-student-course) setting. Reported separately per workflow.

    Measured: Through completion of prosthetic treatment, an average of 6 weeks.

  11. Estimated personnel-related process cost

    Estimated personnel-related process cost per participant, in Swiss francs (CHF): prospectively recorded active clinical and dental laboratory working times multiplied by predefined personnel cost rates (separate rates for clinical and dental laboratory time). Restricted to participants treated in the specialist (non-student-course) setting. Reported separately per workflow.

    Measured: Through completion of prosthetic treatment, an average of 6 weeks.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Oct 2026
  2. Study startNov 2026 (estimated)
  3. Primary completionNov 2029 (estimated)
  4. Study completionMar 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
70 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07903662
Sponsor's protocol ID
DIGICLASP
Other IDs
Req-2026-01413
Acronym
DIGICLASP
Status last verified
Oct 2026
First submitted
12 Oct 2026
Last updated
29 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be publicly shared. The data-protection framework of this internal quality-control project does not provide for unrestricted public sharing of coded participant-level data. Aggregated results will be published in a peer-reviewed journal.

Publications

  • Almufleh B, Arellanob A, Tamimi F. Patient-reported outcomes and framework fit accuracy of removable partial dentures fabricated using digital techniques: A systematic review and meta-analysis. J Prosthodont. 2024 Aug;33(7):626-636. doi: 10.1111/jopr.13786. Epub 2023 Nov 20.

    PubMed 37930081
  • Chia VAP, See Toh YL, Quek HC, Pokharkar Y, Yap AU, Yu N. Comparative clinical evaluation of removable partial denture frameworks fabricated traditionally or with selective laser melting: A randomized controlled trial. J Prosthet Dent. 2024 Jan;131(1):42-49. doi: 10.1016/j.prosdent.2021.12.021. Epub 2022 Mar 5.

    PubMed 35260255
  • Tregerman I, Renne W, Kelly A, Wilson D. Evaluation of removable partial denture frameworks fabricated using 3 different techniques. J Prosthet Dent. 2019 Oct;122(4):390-395. doi: 10.1016/j.prosdent.2018.10.013. Epub 2019 Apr 1.

    PubMed 30948301
  • Elgamal M, Ibrahim AM, Fadl BT, Ragheb NA. Accuracy assessment of removable partial denture frameworks fabricated by selective laser melting using two different workflows: A cross-over clinical study. BMC Oral Health. 2025 May 28;25(1):824. doi: 10.1186/s12903-025-06214-9.

    PubMed 40437453

Questions about this trial

What is this clinical trial studying?

An observational study of Partial Edentulism, run by University of Bern at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 29 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Sebastian Hinz, Dr. med. dent. (+41 31 684 07 41, sebastian.hinz@unibe.ch), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cumulative active prosthesis-related clinical chairside time (time frame: From the first prosthesis-related appointment through definitive insertion, an average of 6 weeks per participant.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07903662, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in